RAPID mRNA Display via Artificial RNA Catalyst
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional mRNA display methods require separate steps for transcription and translation, and the linkage between mRNA and puromycin requires external ligation, which is inefficient and limits the ability to perform complex formation within a single cell-free translation system.
Innovation Solution
The RAPID display method uses a reconstituted cell-free translation system with a linker molecule that aminoacylates an mRNA, allowing for simultaneous transcription, translation, and linker-mRNA complex formation, enabling the formation of an mRNA-peptide conjugate in a single reaction vessel using an artificial RNA catalyst to mediate aminoacylation and hybridization for stable linkage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If separate steps are used for transcription and translation in conventional mRNA display methods, then the processes can be performed with established protocols, but the overall process time and complexity increase
Solution Approach 1:
The patent combines transcription and translation reactions into a single cell-free system by using a plasmid DNA template that can be directly transcribed and translated without isolating the mRNA intermediate. This merging of steps reduces total process time while maintaining reliability through the use of optimized reaction conditions and components.
Solution Approach 2:
The plasmid DNA template is pre-designed with specific features including a T7 promoter for transcription, a ribosome binding site for translation initiation, and a puromycin incorporation sequence. These preliminary design elements enable the coupled transcription-translation system to proceed efficiently without intermediate purification steps.
2Manufacturing precision
If external ligation is used to attach puromycin to mRNA, then the linkage can be formed, but additional reagents and steps are required increasing process complexity
Solution Approach 1:
The system uses self-assembling components where the puromycin is incorporated into the peptide chain during translation by the ribosome, automatically forming the peptide-mRNA conjugate without requiring external ligation enzymes or reagents. The ribosome itself performs the conjugation function as part of its natural translation mechanism.
Solution Approach 2:
The plasmid DNA template serves as an intermediary that encodes both the peptide sequence and the puromycin incorporation site. This single template molecule guides both transcription and translation, and the resulting peptide automatically links to the mRNA through puromycin incorporation during the translation process.
3Ease of manufacture
If a reconstituted cell-free system is used for simultaneous transcription and translation, then the process is simplified to a single reaction vessel, but the system requires careful optimization of multiple components
Solution Approach 1:
The plasmid DNA template is designed to perform multiple functions: serving as the transcription template, encoding the peptide sequence, specifying the puromycin incorporation site, and providing ribosome binding information. This multi-functionality reduces the number of separate components needed while maintaining system versatility through modular plasmid design.
Solution Approach 2:
The system uses defined concentrations of essential components including T7 RNA polymerase, ribosomes, amino acids, and energy sources in the reaction buffer. These optimized parameters enable simultaneous transcription and translation to proceed efficiently in a single vessel, balancing simplicity with adaptability through可调 concentrations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the process of preparing mRNA-peptide conjugates, enhances stability, and allows for the synthesis of unusual peptides with improved binding affinity and stability, facilitating the construction of peptide libraries for drug candidate screening.
Implementation Method 1
a peptidyl acceptor region having a group capable of binding to the translation product by peptidyl transfer reaction at the other end of the linker, wherein the peptidyl acceptor region has a structure containing an amino acid attached to an oligo RNA consisting of a nucleotide sequence of ACCA via an ester bond; and said ester bond is formed by an aminoacylation reaction using an artificial RNA catalyst
Implementation Method 2
a single-stranded structure region having side chain bases pairing with the bases at the 3′-end of the mRNA at one end of the linker
Implementation Method 3
the translated peptide molecule is fused to the mRNA via the puromycin
Data Source
AI summary
Provided are linkers suitable for preparing a conjugate of a nucleic acid and a peptide as a translation product thereof in a reconstituted cell-free translation system in genotype-phenotype mapping (display methods), said linkers comprising a single-stranded structure region having a side chain base pairing with the base at the 3′-end of an mRNA at one end and a peptidyl acceptor region containing an amino acid attached to an oligo RNA consisting of a nucleotide sequence of ACCA via an ester bond at the other end, characterized in that the ester bond is formed by using an artificial RNA catalyst. Also provided are display methods using [mRNA]-[linker]-[peptide] conjugates assembled via such linkers.